The Lincolnian Online logo

The Latest Headlines at The Lincolnian Online

Image about Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Receives $8.75 Consensus Target Price from Brokerages

Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Receives $8.75 Consensus Target Price from Brokerages

Shares of Iovance Biotherapeutics, Inc. (NASDAQ:IOVA – Get Free Report) have received an average rating of “Hold” from the eleven ratings firms that are presently covering the stock, MarketBeat Ratings reports. Two... More of this article »
Image about MiniMed Group Inc’s Lock-Up Period To Expire  on September 2nd (NASDAQ:MMED)

MiniMed Group Inc’s Lock-Up Period To Expire on September 2nd (NASDAQ:MMED)

MiniMed Group’s (NASDAQ:MMED – Get Free Report) lock-up period is set to end on Wednesday, September 2nd. MiniMed Group had issued 28,000,000 shares in its public offering on March 6th. The total size of the offering was... More of this article »
Image about Real Brokerage (NASDAQ:REAX) Price Target Raised to $40.00

Real Brokerage (NASDAQ:REAX) Price Target Raised to $40.00

Real Brokerage (NASDAQ:REAX – Free Report) had its price objective raised by JonesTrading from $4.00 to $40.00 in a report published on Tuesday morning,Benzinga reports. JonesTrading currently has a buy rating on the stock. A... More of this article »
Image about Four Corners Property Trust’s (FCPT) “Market Outperform” Rating Reiterated at Citizens Jmp

Four Corners Property Trust’s (FCPT) “Market Outperform” Rating Reiterated at Citizens Jmp

Citizens Jmp reaffirmed their market outperform rating on shares of Four Corners Property Trust (NYSE:FCPT – Free Report) in a research report sent to investors on Tuesday morning,Benzinga reports. The brokerage currently has... More of this article »
Image about Evolus’ (EOLS) “Buy” Rating Reiterated at HC Wainwright

Evolus’ (EOLS) “Buy” Rating Reiterated at HC Wainwright

HC Wainwright reiterated their buy rating on shares of Evolus (NASDAQ:EOLS – Free Report) in a research note released on Tuesday,Benzinga reports. They currently have a $13.00 price objective on the stock. Other equities research... More of this article »
Image about Beam Therapeutics’ (BEAM) Buy Rating Reiterated at HC Wainwright

Beam Therapeutics’ (BEAM) Buy Rating Reiterated at HC Wainwright

HC Wainwright restated their buy rating on shares of Beam Therapeutics (NASDAQ:BEAM – Free Report) in a research report report published on Tuesday,Benzinga reports. The brokerage currently has a $80.00 price target on the stock. Other... More of this article »
Image about Capricor Therapeutics (NASDAQ:CAPR) Upgraded at Oppenheimer

Capricor Therapeutics (NASDAQ:CAPR) Upgraded at Oppenheimer

Oppenheimer upgraded shares of Capricor Therapeutics (NASDAQ:CAPR – Free Report) from a market perform rating to an outperform rating in a report released on Tuesday, MarketBeat Ratings reports. CAPR has been the subject of a... More of this article »
Image about Synchrony Financial (NYSE:SYF) Price Target Raised to $90.00

Synchrony Financial (NYSE:SYF) Price Target Raised to $90.00

Synchrony Financial (NYSE:SYF – Free Report) had its target price increased by Wolfe Research from $85.00 to $90.00 in a research report sent to investors on Tuesday morning,Benzinga reports. They currently have an outperform... More of this article »
Image about Merck & Co., Inc. (NYSE:MRK) Price Target Raised to $180.00

Merck & Co., Inc. (NYSE:MRK) Price Target Raised to $180.00

Merck & Co., Inc. (NYSE:MRK – Free Report) had its price objective boosted by Wolfe Research from $155.00 to $180.00 in a research note published on Tuesday morning,Benzinga reports. They currently have an outperform rating... More of this article »
Image about Beam Global (NASDAQ:BEEM) Cut to Hold at Freedom Broker

Beam Global (NASDAQ:BEEM) Cut to Hold at Freedom Broker

Freedom Broker cut shares of Beam Global (NASDAQ:BEEM – Free Report) from a buy rating to a hold rating in a report published on Tuesday morning, MarketBeat.com reports. They currently have $1.50 price objective on the stock. A... More of this article »
Image about Tema Space Innovators ETF (NYSEARCA:NASA) Trading Up 1.9%  – What’s Next?

Tema Space Innovators ETF (NYSEARCA:NASA) Trading Up 1.9% – What’s Next?

Tema Space Innovators ETF (NYSEARCA:NASA – Get Free Report) shares were up 1.9% on Thursday . The stock traded as high as $24.11 and last traded at $24.08. 814,010 shares changed hands during mid-day trading, a decline of 81%... More of this article »
Image about Computer Modelling Group (OTCMKTS:CMDXF) Stock Price Up 2.5%  – Time to Buy?

Computer Modelling Group (OTCMKTS:CMDXF) Stock Price Up 2.5% – Time to Buy?

Computer Modelling Group Ltd. (OTCMKTS:CMDXF – Get Free Report) shares shot up 2.5% during trading on Thursday . The company traded as high as $3.00 and last traded at $2.92. Approximately 14,811 shares traded hands during trading,... More of this article »
Image about TD Cuts H&R Real Estate Investment Trust (TSE:HR.UN) Price Target to C$11.00

TD Cuts H&R Real Estate Investment Trust (TSE:HR.UN) Price Target to C$11.00

H&R Real Estate Investment Trust (TSE:HR.UN – Free Report) had its price objective reduced by TD from C$11.50 to C$11.00 in a research report released on Tuesday,BayStreet.CA reports. They currently have a buy rating on... More of this article »
Image about Salesforce’s (CRM) Buy Rating Reiterated at Canaccord Genuity Group

Salesforce’s (CRM) Buy Rating Reiterated at Canaccord Genuity Group

Canaccord Genuity Group restated their buy rating on shares of Salesforce (NYSE:CRM – Free Report) in a report released on Tuesday,Benzinga reports. The firm currently has a $225.00 price objective on the CRM provider’s... More of this article »
Image about Luye Pharma Group (LYPHF) to Announce Quarterly Earnings on Saturday

Luye Pharma Group (LYPHF) to Announce Quarterly Earnings on Saturday

Luye Pharma Group (OTCMKTS:LYPHF – Get Free Report) is expected to post its resultson Saturday, August 29th. Analysts expect Luye Pharma Group to announce earnings of $0.0074 per share and revenue of $465.3280 million for the... More of this article »